MARK S. ORDAN - 11 May 2023 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role
Director
Signature
/s/ Mary Ann E. Moore, Attorney-in-Fact
Issuer symbol
MD
Transactions as of
11 May 2023
Net transactions value
$0
Form type
4
Filing time
15 May 2023, 17:00:31 UTC
Previous filing
03 May 2023
Next filing
26 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Award $0 +9,463 +5.5% $0.000000 180,923 11 May 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with annual equity award. Shares will vest on May 11, 2024.
F2 Excludes 76,253 previously reported shares of restricted common stock granted to the reporting person pursuant to the Plan in connection with an annual equity award that were forfeited because the performance-based criteria were not achieved.